Last edition
News about "US FDA approval for generic Ancobon capsules"
Aurobindo Pharma receives US FDA approval for generic Ancobon capsules
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (FDA) to manufacture and market flucytosine capsules, 250 mg and 500 mg
US FDA Approval For Generic Ancobon Capsules | 04/05/2020 | By Darshana | 724
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members